Second Sight Medical Products Inc
EYESW · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $13 | $13 | $13 | $12 |
| - Cash | $3 | $7 | $13 | $18 |
| + Debt | $18 | $19 | $19 | $19 |
| Enterprise Value | $29 | $25 | $19 | $13 |
| Revenue | $0 | $0 | $0 | -$0 |
| % Growth | – | – | 100% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | 50% |
| EBITDA | -$7 | -$7 | -$7 | -$19 |
| % Margin | – | – | – | 7,412,370.4% |
| Net Income | -$7 | -$7 | -$6 | -$20 |
| % Margin | – | – | – | 7,876,568.8% |
| EPS Diluted | -0.11 | -0.12 | -0.11 | -0.35 |
| % Growth | 8.3% | -9.1% | 68.6% | – |
| Operating Cash Flow | -$4 | -$8 | -$5 | -$20 |
| Capital Expenditures | -$1 | -$0 | -$0 | -$1 |
| Free Cash Flow | -$5 | -$8 | -$5 | -$20 |